News & partners

Dianosic is a biotech focused on the development of novel solutions integrated drug and
delivery system for the localized treatment of patients with chronic rhinitis and chronic rhinosinusitis.

Latest news

Mar 31, 2021

Challenges – Dianosic has been selected among the 100 most innovative startups to invest in 2021

See more
Sep 21, 2020

Marc Augustin: B SMART Interview

See more
Jun 22, 2020

The Medtech Strategist x Dianosic

See more
Apr 23, 2020

Talent 4 boards x Dianosic

See more

They support us

Our investors

We built a solid network of partners to support company funding and growth.

Wiseed
Bpi France
Fondation Force
Eurométropole de Strasbourg
Banque Populaire Rives de Paris
Caisse d’épargne Grand Est
La Région Grand Est